Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography - PubMed (original) (raw)
Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography
Peifeng Dai et al. Exp Ther Med. 2015 Sep.
Abstract
Diabetes and hypertension are complex and serious diseases that may ultimately lead to renal complications. Adequate control of blood glucose and blood pressure contributes to decreased renal risks, but may not be sufficient for certain patients. The current study was undertaken to investigate the renoprotective effects of berberine as an adjuvant therapy to standard hypotensive and hypoglycemic treatment in hypertensive patients with type 2 diabetes mellitus (T2DM). In this 2-year clinical study, 69 hypertensive patients with T2DM, whose blood pressure and fasting plasma glucose (FPG) were adequately controlled by hypotensive and oral hypoglycemic agents prior to the study, were enrolled and randomly assigned into control (33 cases) and add-on (36 cases) groups. Berberine was orally administrated to the patients in the add-on group concomitantly with standard hypotensive and hypoglycemic treatment. Baseline characteristics, including the levels of FPG, glycated hemoglobin, systolic blood pressure, diastolic blood pressure, serum creatinine, urinary albumin-to-creatine ratio (UACR), urinary osteopontin and kidney injury molecule-1 (KIM-1) were determined. Furthermore, the oxidative stress markers malondialdehyde, urinary 8-hydroxy-2'-deoxyguanosine, superoxide dismutase, glutathione peroxidase and total-antioxidant capacity, and the inflammatory parameters vascular adhesion molecule-1, C-reactive protein and high molecular weight-adiponectin were evaluated. In addition, ultrasonographic parameters, including peak systolic velocity, end diastolic velocity and renal arterial resistance index were determined. After treatment, it was observed that the control and add-on treatments were able to adequately control blood pressure and blood glucose. Patients in the add-on group exhibited significant reductions in renal damage biochemical markers (UACR, urinary osteopontin and KIM-1) and improved renal hemodynamics, in addition to reduced inflammation and oxidative stress. The present results suggest that berberine is beneficial for hypertensive patients with T2DM as add-on therapy to standard hypotensive and hypoglycemic agents.
Keywords: add-on therapy; berberine; color Doppler ultrasonography; hypertension; renoprotective effect; type 2 diabetes mellitus.
Similar articles
- [Effects of berberine on the serum cystatin C levels and urine albumin/creatine ratio in patients with type 2 diabetes mellitus].
Li ZY, Liu B, Zhuang XJ, Shen YD, Tian HR, Ji Y, Li LX, Liu F. Li ZY, et al. Zhonghua Yi Xue Za Zhi. 2018 Dec 11;98(46):3756-3761. doi: 10.3760/cma.j.issn.0376-2491.2018.46.007. Zhonghua Yi Xue Za Zhi. 2018. PMID: 30541217 Clinical Trial. Chinese. - Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats.
Guo Z, Sun H, Zhang H, Zhang Y. Guo Z, et al. Clin Exp Hypertens. 2015;37(4):332-9. doi: 10.3109/10641963.2014.972560. Epub 2015 Apr 13. Clin Exp Hypertens. 2015. PMID: 25867076 - Ameliorative effect of berberine against gentamicin-induced nephrotoxicity in rats via attenuation of oxidative stress, inflammation, apoptosis and mitochondrial dysfunction.
Adil M, Kandhare AD, Dalvi G, Ghosh P, Venkata S, Raygude KS, Bodhankar SL. Adil M, et al. Ren Fail. 2016 Jul;38(6):996-1006. doi: 10.3109/0886022X.2016.1165120. Epub 2016 Apr 8. Ren Fail. 2016. PMID: 27056079 - Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G. Lan J, et al. J Ethnopharmacol. 2015 Feb 23;161:69-81. doi: 10.1016/j.jep.2014.09.049. Epub 2014 Dec 10. J Ethnopharmacol. 2015. PMID: 25498346 Review. - Spironolactone Add-on for Preventing or Slowing the Progression of Diabetic Nephropathy: A Meta-analysis.
Hou J, Xiong W, Cao L, Wen X, Li A. Hou J, et al. Clin Ther. 2015 Sep;37(9):2086-2103.e10. doi: 10.1016/j.clinthera.2015.05.508. Epub 2015 Aug 5. Clin Ther. 2015. PMID: 26254276 Review.
Cited by
- The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis.
Zamani M, Zarei M, Nikbaf-Shandiz M, Hosseini S, Shiraseb F, Asbaghi O. Zamani M, et al. Front Nutr. 2022 Oct 14;9:1013055. doi: 10.3389/fnut.2022.1013055. eCollection 2022. Front Nutr. 2022. PMID: 36313096 Free PMC article. - Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders.
Neag MA, Mocan A, Echeverría J, Pop RM, Bocsan CI, Crişan G, Buzoianu AD. Neag MA, et al. Front Pharmacol. 2018 Aug 21;9:557. doi: 10.3389/fphar.2018.00557. eCollection 2018. Front Pharmacol. 2018. PMID: 30186157 Free PMC article. Review. - Berberine Influences Blood Glucose via Modulating the Gut Microbiome in Grass Carp.
Pan H, Li Z, Xie J, Liu D, Wang H, Yu D, Zhang Q, Hu Z, Shi C. Pan H, et al. Front Microbiol. 2019 May 9;10:1066. doi: 10.3389/fmicb.2019.01066. eCollection 2019. Front Microbiol. 2019. PMID: 31143174 Free PMC article. - A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome.
Tabeshpour J, Imenshahidi M, Hosseinzadeh H. Tabeshpour J, et al. Iran J Basic Med Sci. 2017 May;20(5):557-568. doi: 10.22038/IJBMS.2017.8682. Iran J Basic Med Sci. 2017. PMID: 28656091 Free PMC article. Review. - Role of berberine in Alzheimer's disease.
Cai Z, Wang C, Yang W. Cai Z, et al. Neuropsychiatr Dis Treat. 2016 Oct 3;12:2509-2520. doi: 10.2147/NDT.S114846. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 27757035 Free PMC article. Review.
References
- Takatsu M, Hattori T, Murase T, Ohtake M, Kato M, Nashima K, Nakashima C, Takahashi K, Ito H, Niinuma K, Aritomi S, et al. Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats. J Hypertens. 2012;30:1845–1855. doi: 10.1097/HJH.0b013e3283567645. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials